CAPT-ACTP 2022

“Embracing Change and Uncertainty to Improve the Health of Canadians”

October 17-18, 2022

MaRS Discovery District

Toronto, ON

PROGRAM

Click here for Final Program 

SLIDE DECKS

Keynote openingPATHWAYS – Indigenous Health Collaborations  (Sponsored by: Boehringer Ingelheim Canada) click here for video

Session 1: The use of real-world evidence in real-world decisions: How is it used internationally and are there lessons for Canada? (Sponsored by                           Eisai Ltd)

Session 2:   Tackling Pan-Country Evidence in Oncology: Multi-stakeholder Partnership and Innovative Technology Made Simple. Who’s in?                                     (Sponsored by: IQVIA Canada)

Session 3:  Rare Disease Strategy in Canada: Where are we Going? (Sponsored by: Innomar Strategies) (no slides)

Session 4:  Testing and Precision Therapies: Can Health Systems Integrate Drug and Diagnostic Access in Uncertain Times? (Sponsored by:                                          Innovative Medicines Canada)

Breakfast Workshop: Early-Stage Cancer Therapies: How Can Canadian Evaluators and Funders Adapt to Review Treatments With Surrogate                                                      Endpoints?  (Sponsored by: CanCertainty)

Session 5:   Hot topics in Cancer Health Technology Assessments and Reimbursement: Surrogate Endpoints, Funding Algorithms and Cost-                                    Effectiveness Thresholds (Sponsored by: Merck Canada) No slides

Session 6: National Landscape Panel: At a Population Level, How Do We Choose a Willingness to Pay Threshold? (Sponsored by: Janssen Inc.)

Session 7: It’s Time to Put Patients at the Front of the Line. Rapid Access for Project Orbis Drugs Could be a Start (Sponsored by: AstraZeneca Canada)

POSTER GALLERY

 

 

Published Abstracts 

 

Awards

CAPT is pleased to announce that the 2022 Kris Schindel Award Recipient is Kim Yoong

Winners of the Dr. E. Keith Borden Award for Student Poster Presentation are:

Ria Garg
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis
Abstract # 14

Anna Rzepka
Impact of the COVID-19 pandemic on the proportion of patients who received on-time denosumab dispensations, by prior denosumab
history
Poster # 19

DSECT Alumni Recognition Award Recipients

  • Catrina Loucks, Assistant Professor and Investigator, University of British Columbia and BC Children’s Hospital Research Institute
  • Faizan Khan, Epidemiologist, National Advisory Committee on Immunization, Public Health Agency of Canada
  • Jennifer DonnanAssistant Professor, Memorial University of Newfoundland
  • Jennifer Watt, Assistant Professor, University of Toronto; Academic Geriatrician/Clinical Scientist, St. Michael’s Hospital; Scientist, Li Ka Shing Knowledge Institute
  • Kaley Hayes, Assistant Professor, Brown University School of Public Health, Department of Health Services, Policy and Practice
  • Michael Fralick, Assistant Professor & Clinician Scientist, University of Toronto & Sinai Health/University Health Network
  • Mina TadrousAssistant Professor, University of Toronto Leslie Dan Faculty of Pharmacy
  • Shanna Trenaman, Assistant Professor, Dalhousie University

PARTNERS

CAPT-ACTP gratefully acknowledges our 2022 partners:

Platinum
AstraZeneca
Eisai
Innomar Strategies
Innovative Medicines Canada
IQVIA
Janssen
Merck Canada

Gold
Boehringer-Ingelheim Canada Ltd.
CanCertainty

Silver
Astellas
Biogen
CADTH
Gilead
Novartis
PDCI Market Access

Bronze
Amgen
CSL Behring Canada
Exactis Innovation
HOPE Research Centre
J.L. Glennie Consulting Inc.
Sanofi

Academic Partner
DSECT

PLATINUM PARTNERS:       

 

GOLD PARTNERS:                                     

 

SILVER PARTNERS:              

 


BRONZE PARTNERS:                 

 

 

 


Learn more about CAPT-ACTP!

CAPT ACTP Brochure